8 results match your criteria: "Johns Hopkins Bloomberg School of Public Health **Department of Medicine[Affiliation]"
Med Care
July 2017
*Department of Health Policy & Management, Johns Hopkins Bloomberg School of Public Health †Center for Drug Safety and Effectiveness, Johns Hopkins University, Baltimore ‡Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health §Department of Medicine, Division of General Internal Medicine, Johns Hopkins Medicine, Baltimore, MD.
Background: Buprenorphine-naloxone treatment for opioid use disorder has rapidly expanded, yet little is known about treatment outcomes among patients in the general population.
Objective: To examine predictors of treatment duration, dosage, and continuity in a diverse community setting.
Research Design: We examined QuintilesIMS Real World Data, an all-payer, pharmacy claims database, to conduct an analysis of individuals age 18 years and above initiating buprenorphine-naloxone treatment between January 2010 and July 2012 in 11 states.
AIDS
October 2016
aDivision of Infectious Diseases, Feinberg School of Medicine, Northwestern University, Chicago, Illinois bDepartment of Epidemiology, Johns Hopkins Bloomberg School of Public Health cDepartment of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland dLos Angeles Biomedical Research Institute at Harbor-UCLA Medical Center, Torrance, California eDepartment of Infectious Diseases and Microbiology, University of Pittsburgh Graduate School of Public Health, Pittsburgh, Pennsylvania, USA.
Objectives: HIV infection is associated with increased prevalence of subclinical coronary plaque. The extent to which such plaque reflects effects of HIV infection or effects of long-term antiretroviral therapy (ART) use remains unclear and was the goal of this analysis.
Design And Methods: We compared the prevalence and extent of coronary plaque and stenosis between users of specific ART drugs or drug classes using coronary computed tomography (CT) among HIV-infected men in the Multicenter AIDS Cohort Study.
Med Care
September 2016
*Department of Health Policy & Management †Center for Drug Safety and Effectiveness, Johns Hopkins Bloomberg School of Public Health ‡Department of Medicine, Division of Geriatric Medicine and Gerontology, School of Medicine, Johns Hopkins University §Center for Population Health Information Technology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD.
Background: High-cost users in a period may not incur high-cost utilization in the next period. Consistent high-cost users (CHUs) may be better targets for cost-saving interventions.
Objectives: To compare the characteristics of CHUs (patients with plan-specific top 20% medical costs in all 4 half-year periods across 2008 and 2009) and point high-cost users (PHUs) (top users in 2008 alone), and to build claims-based models to identify CHUs.
J Infect Dis
July 2016
Department of Medicine Department of Microbiology and Immunology.
Background: The relevance of antibodies (Abs) in the defense against Mycobacterium tuberculosis infection remains uncertain. We investigated the role of Abs to the mycobacterial capsular polysaccharide arabinomannan (AM) and its oligosaccharide (OS) fragments in humans.
Methods: Sera obtained from 29 healthy adults before and after primary or secondary bacillus Calmette-Guerin (BCG) vaccination were assessed for Ab responses to AM via enzyme-linked immunosorbent assays, and to AM OS epitopes via novel glycan microarrays.
Clin J Pain
April 2016
*Center for Drug Safety and Effectiveness Departments of †Epidemiology ‡Mental Health, Johns Hopkins Bloomberg School of Public Health **Department of Medicine, Division of General Internal Medicine, Johns Hopkins Medicine, Baltimore, MD §Stefan P. Kruszewski, MD & Associates, Harrisburg, PA ∥Phoenix House Foundation #Global Institute for Public Health, New York University, New York, NY ¶Heller School for Social Policy and Management, Brandeis University, Waltham, MA.
Objectives: Physicians are a key stakeholder in the epidemic of prescription opioid abuse. Therefore, we assessed their knowledge of opioid abuse and diversion, as well as their support for clinical and regulatory interventions to reduce opioid-related morbidity and mortality.
Materials And Methods: We conducted a nationally representative postal mail survey of 1000 practicing internists, family physicians, and general practitioners in the United States between February and May 2014.
AIDS
January 2014
aDepartment of Epidemiology, Johns Hopkins Bloomberg School of Public Health bDepartment of Medicine, Johns Hopkins School of Medicine, Baltimore, Maryland cDepartment of Medicine, Northwestern University Feinberg School of Medicine, Chicago, Illinois dGraduate School of Public Health, Department of Infectious Diseases and Microbiology, University of Pittsburgh, Pittsburgh, Pennsylvania eLos Angeles Gay and Lesbian Center, Los Angeles, California fWelch Center for Prevention, Epidemiology and Clinical Research, Baltimore, Maryland gDepartment of Pediatrics, University of Rochester Medical Center, Rochester, New York, USA.
Objective: Diabetes and hypertension, common conditions in antiretroviral-treated HIV-infected individuals, are associated with glomerular hyperfiltration, which precedes the onset of proteinuria and accelerated kidney function decline. In the Multicenter AIDS Cohort Study, we examined the extent to which hyperfiltration is present and associated with metabolic, cardiovascular, HIV and treatment risk factors among HIV-infected men.
Design: Cross-sectional cohort using direct measurement of glomerular filtration rate by iohexol plasma clearance for 367 HIV-infected men and 241 HIV-uninfected men who were free of chronic kidney disease.
Med Care
January 2014
*Department of Health Policy and Management, Johns Hopkins Bloomberg School of Public Health †Department of Medicine, Division of General Internal Medicine, Johns Hopkins University School of Medicine ‡Department of Population, Family and Reproductive Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD.
Background: The "Unborn Child" (UC) option provides state Medicaid/Children's Health Insurance Program (CHIP) programs with a new strategy to extend prenatal coverage to low-income women who would otherwise have difficulty enrolling in or would be ineligible for Medicaid.
Objectives: To examine the association of the UC option with the probability of enrollment in Medicaid/CHIP during pregnancy and probability of receiving adequate prenatal care.
Research Design: We use pooled cross-sectional data from the Pregnancy Risk Assessment Monitoring System from 32 states between 2004 and 2010 (n = 81,983).
Med Care
October 2013
*Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health †Center for Drug Safety and Effectiveness, Johns Hopkins University ‡Department of Health Policy and Management, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD §Division of Health Care Policy and Research, Mayo Clinic, Rochester, MN ∥Program on Prevention Outcomes and Practices, Stanford Prevention Research Center, Stanford University School of Medicine, Palo Alto, CA ¶Stefan P. Kruszewski, MD & Associates, Harrisburg, PA #Department of Mental Health, Johns Hopkins Bloomberg School of Public Health **Department of Medicine, Division of General Internal Medicine, Johns Hopkins Medicine, Baltimore, MD.
Background: Escalating rates of prescription opioid use and abuse have occurred in the context of efforts to improve the treatment of nonmalignant pain.
Objective: The aim of the study was to characterize the diagnosis and management of nonmalignant pain in ambulatory, office-based settings in the United States between 2000 and 2010.
Design, Setting, And Participants: Serial cross-sectional and multivariate regression analyses of the National Ambulatory Medical Care Survey (NAMCS), a nationally representative audit of office-based physician visits, were conducted.